Lv5
1170 积分 2023-09-02 加入
Measurable Residual FLT3 Internal Tandem Duplication Before Allogeneic Transplant for Acute Myeloid Leukemia
20天前
已完结
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant
20天前
已完结
Indeterminate measurable residual disease by multiparameter flow cytometry is associated with an intermediate risk of clinical relapse in adult patients with acute leukaemia
21天前
已完结
ICUS, IDUS, CHIP and CCUS: Diagnostic Criteria, Separation from MDS and Clinical Implications
25天前
已完结
Review of flow cytometry findings and associated scoring approaches for identifying myelodysplastic syndrome and the future role of machine learning in improving the diagnostic algorithm
25天前
已完结
Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial
25天前
已完结
Luspatercept versus epoetin alfa in erythropoiesis-stimulating agent-naive, transfusion-dependent, lower-risk myelodysplastic syndromes (COMMANDS): primary analysis of a phase 3, open-label, randomised, controlled trial
25天前
已完结
Molecular International Prognostic Scoring System for Myelodysplastic Syndromes
25天前
已完结
Monitoring of measurable residual disease by next‐generation sequencing in patients with acute myeloid leukaemia
27天前
已完结
2025 update on MRD in acute myeloid leukemia: a consensus document from the ELN-DAVID MRD Working Party
28天前
已完结
皖公网安备34019202002308
